Diagnostic maker Cellex has announced plans to develop a rapid coronavirus infection test that people can fully perform at home, from sample collection to result—with 15-minute readings double-checked by a personal smartphone app.
Mallinckrodt is joining forces with Transimmune on extracorporeal photopheresis research. The specialty pharma offers photopheresis as a treatment for skin symptoms linked to cutaneous T-cell lymphoma; the partners aim to boost understanding of how this mechanism works and potentially develop next-generation technologies for the treatment and expand its use to several other immune-mediated diseases. The partners also plan to bring the technology platform through new clinical trials.
Cellex-C International Inc. Receives FDA Warning Letter
Cellex-C International on FDA Import Alert List For Drugs From Firms Which Have Not Met Drug GMPs